Celgene, Agios Settle $1B UPenn Cancer Research Suits

Law360, New York (September 4, 2012, 1:19 PM EDT) -- Agios Pharmaceuticals Inc. and Celgene Corp. have agreed to settle two lawsuits brought by the University of Pennsylvania in New York federal court over a former university researcher's alleged use of more than $1 billion worth of patentable, university-funded cancer research to form Agios, the companies announced Friday.

While most of the terms of the settlement are confidential, Cambridge, Mass.-based drug developer Agios and the university have drawn up a licensing agreement for intellectual property focused on developing cancer metabolism diagnostic products as part of the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.